However, five pathways were commonly and uniquely enriched by mutations and aberrant gene expression in NASH-HCCs; these include calcium, insulin signaling, cell adhesion, axon guidance and metabolic pathways (Fig. 6d). This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.